Schoemaker C G, Prakken A B J, Furth E F
Rijksinstituut voor Volksgezondheid en Milieu, Centrum Kennisintegratie Volksgezondheid en Zorg, Bilthoven.
Ned Tijdschr Geneeskd. 2017;161:D1764.
The British James Lind Alliance (JLA) has developed a method to allow practitioners, patients and family members together to develop a research agenda for a disease or a form of treatment. In a 'priority setting partnership', they gradually establish a top-10 list of the most important unanswered research questions. Input from patients and their relatives is given the same weight when determining priorities as that from practitioners. More than 50 of these top-10 lists have been created so far, one of which was created in the Netherlands. The JLA method combines elements of the two very different methods currently prevailing in the Netherlands: the dialog model, developed by the VU and the 'health care evaluation agenda', developed by the Dutch Association of Medical Specialists. The JLA method is quite practicable and leads to new research questions. The biggest advantage is that it leads to a dialogue between creators and users of knowledge about what the relevant research questions are.
英国詹姆斯·林德联盟（JLA）开发了一种方法，让从业者、患者及其家属共同为一种疾病或一种治疗方式制定研究议程。在“确定优先事项伙伴关系”中，他们逐步确定最重要的未解决研究问题的前10名清单。在确定优先事项时，患者及其亲属的意见与从业者的意见具有同等权重。到目前为止，已经创建了50多个这样的前10名清单，其中一个是在荷兰创建的。JLA方法结合了荷兰目前流行的两种截然不同的方法的元素：由VU开发的对话模型和由荷兰医学专家协会开发的“医疗保健评估议程”。JLA方法相当实用，并能引出新的研究问题。最大的优势在于，它能促使知识的创造者和使用者就相关研究问题展开对话。
